Japan’s Olympus inks global distribution agreement with Korean startup EndoRobotics
May 5, 2026 | Tuesday | News
Partnership aimed at expanding patient access to advanced EndoTherapeutic procedures
Olympus Corporation, a Japanese MedTech company committed to advancing endoscopy-enabled care, has signed an exclusive global distribution agreement with South Korea-based startup EndoRobotics. Under this agreement, robot-assisted technologies manufactured by EndoRobotics will be distributed globally by Olympus exclusively as part of its EndoTherapy portfolio.
This collaboration will help drive broader adoption of advanced endoscopic procedures —such as endoscopic submucosal dissection (ESD) — helping clinicians deliver organ-sparing, minimally invasive care with precision and confidence.
Olympus aims to expand patient access to endoscopic procedures for treatment of early-stage cancers and precancerous lesions of the GI tract. By removing diseased tissue without resecting the organ, physicians performing ESD may allow for less procedural risk, fewer post-treatment complications and shorter patient recovery.
EndoRobotics technologies can enhance precision, control and efficiency in complex procedures such as ESD. These technologies play an increasingly important role in supporting consistent outcomes, particularly as the global incidence of GI cancers continues to rise.